Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 800 of 808 entries
View as:

LBH589 in Relapsed or Relapsed and Refractory Waldenstrom's Macroglobulinemia

Phase: N/A Priority: Normal
NCT ID: NCT00936611 Org: User:
Start: 07/31/09 End: 11/30/12 Due: 11/30/13

Resource Intervention to Support Equity (RISE) in High-Risk Neuroblastoma

Phase: N/A Priority: Normal
NCT ID: NCT06831552 Org: User:
Start: 04/30/25 End: 06/01/29 Due: 06/01/30

Methylphenidate for Cancer-Related Fatigue

Phase: N/A Priority: Normal
NCT ID: NCT01164956 Org: User:
Start: 07/31/11 End: 03/31/13 Due: 03/31/14

Pilot Study of Zirconium-89 Bevacizumab Positron Emission Tomography for Imaging Angiogenesis in Patients With Inflammatory Breast Carcinoma Receiving Preoperative Chemotherapy

Phase: N/A Priority: Normal
NCT ID: NCT01894451 Org: User:
Start: 06/30/15 End: 03/17/17 Due: 03/17/18

Pilot Feasibility of the Pediatric Cancer Resource Equity (PediCARE) Intervention

Phase: N/A Priority: Normal
NCT ID: NCT03638453 Org: User:
Start: 05/28/19 End: 05/06/22 Due: 05/06/23

Wide Excision Alone As Treatment for Ductal Carcinoma in Situ of the Breast

Phase: N/A Priority: Normal
NCT ID: NCT00165256 Org: User:
Start: 05/31/95 End: 11/30/25 Due: 11/30/26

An Open-Label, Phase Ib/II Clinical Trial Of Cdk 4/6 Inhibitor, Ribociclib (Lee011), In Combination With Trastuzumab Or T-Dm1 For Advanced/Metastatic Her2-Positive Breast Cancer.

Phase: N/A Priority: Normal
NCT ID: NCT02657343 Org: User:
Start: 03/09/16 End: 06/30/22 Due: 06/30/23

A Pilot Study of 18F-FLT in Pediatric Patients With Central Nervous System (CNS) Tumors

Phase: N/A Priority: Normal
NCT ID: NCT00633958 Org: User:
Start: 03/31/08 End: 03/31/10 Due: 03/31/11

Supine MRI in Breast Cancer Patients Undergoing Upfront Surgery or Receiving Neoadjuvant Therapy

Phase: N/A Priority: Normal
NCT ID: NCT02956473 Org: User:
Start: 11/15/16 End: 08/31/22 Due: 08/31/23

Chemotherapy Combined With Radiation Therapy for Newly Diagnosed CNS AT/RT

Phase: N/A Priority: Normal
NCT ID: NCT00084838 Org: User:
Start: 02/28/03 End: 03/31/13 Due: 03/31/14

Genetic Testing for All Breast Cancer Patients (GET FACTS)

Phase: N/A Priority: Normal
NCT ID: NCT04245176 Org: User:
Start: 01/31/20 End: 12/01/25 Due: 12/01/26

Cemiplimab in AlloSCT/SOT Recipients With CSCC

Phase: N/A Priority: Normal
NCT ID: NCT04339062 Org: User:
Start: 11/03/20 End: 03/01/25 Due: 03/01/26

Randomized Amifostine For SCCHN

Phase: N/A Priority: Normal
NCT ID: NCT00095927 Org: User:
Start: 05/31/03 End: 06/30/08 Due: 06/30/09

Bortezomib Plus Tacrolimus and Methotrexate to Prevent Graft Versus Host Disease (GVHD) After Mismatched Allogeneic Non-Myeloablative Blood Stem Cell Transplantation

Phase: N/A Priority: Normal
NCT ID: NCT00369226 Org: User:
Start: 08/31/06 End: 09/30/11 Due: 09/30/12

Detection of Tumor Associated Cell-free DNA in Peritoneal Fluid Obtained by Culdocentesis

Phase: N/A Priority: Normal
NCT ID: NCT02441140 Org: User:
Start: 05/31/15 End: 07/31/19 Due: 07/31/20

A Phase 1 Trial of CD25/Treg-depleted DLI Plus Ipilimumab for Myeloid Disease Relapse After Matched-HCT

Phase: N/A Priority: Normal
NCT ID: NCT03912064 Org: User:
Start: 07/10/19 End: 07/01/25 Due: 07/01/26

Abemaciclib + Pembrolizumab In Glioblastoma

Phase: N/A Priority: Normal
NCT ID: NCT04118036 Org: User:
Start: 12/01/21 End: 12/01/24 Due: 12/01/25

Peri-Transfusion QOL Assessments (PTQA): A New Paradigm of Transfusion Decision Support for Patients With MDS

Phase: N/A Priority: Normal
NCT ID: NCT03660228 Org: User:
Start: 10/17/18 End: 06/30/21 Due: 06/30/22

Move Together Boston Feasibility Pilot (Sit Less, Move More App for Black Breast Cancer Survivors & At-Risk Relatives)

Phase: N/A Priority: Normal
NCT ID: NCT05011279 Org: User:
Start: 09/10/21 End: 01/21/22 Due: 01/21/23

A Phase II Study of Venetoclax in Combination With Dose-adjusted EPOCH-R or R-CHOP for Patients With Richter's Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT03054896 Org: User:
Start: 03/08/17 End: 12/01/27 Due: 12/01/28

Atezolizumab + Sacituzumab Govitecan to Prevent Recurrence in TNBC (ASPRIA)

Phase: N/A Priority: Normal
NCT ID: NCT04434040 Org: User:
Start: 07/02/20 End: 12/30/27 Due: 12/30/28

Monitoring of Erythroid Lineage Specific Chimerism Following Allogeneic Hematopoietic Transplantation for Thalassemia Major

Phase: N/A Priority: Normal
NCT ID: NCT00480506 Org: User:
Start: 04/30/04 End: 10/31/05 Due: 10/31/06

Resistance and Aerobic Exercise for Prevention in Women With Dense Breasts (REP-D)

Phase: N/A Priority: Normal
NCT ID: NCT06322888 Org: User:
Start: 03/28/24 End: 12/31/25 Due: 12/31/26

BOLSTER: Learning New Skills to Thrive

Phase: N/A Priority: Normal
NCT ID: NCT06936878 Org: User:
Start: 05/12/25 End: 09/30/29 Due: 09/30/30

Genetic Testing for Breast, Ovarian, Pancreatic, and Prostate Cancers

Phase: N/A Priority: Normal
NCT ID: NCT04330716 Org: User:
Start: 12/01/20 End: 12/31/23 Due: 12/31/24